Derma Sciences Licenses Novel Angiotensin Analog Technology for Use in Wound Healing,Information on Derma Sciences Licenses Novel Angiotensin Analog Technology for Use in Wound Healing, under Burns & Injuries section of the Health Articles & Reviews; PRINCETON, N.J.----Derma Sciences , a manufacturer and marketer of advanced wound care products, today announced it has acquired a global exclusive licensing contract for DSC127, ... |
![]() |
|
Derma Sciences Licenses Novel Angiotensin Analog Technology for Use in Wound Healing,
by A F Boyle 11-06-2007, 02:40 AM
PRINCETON, N.J.----Derma Sciences , a manufacturer and marketer of advanced wound care products, today announced it has acquired a global exclusive licensing contract for DSC127, a topical application for the treatment of wounds - such as diabetic ulcers, leg ulcers associated with venous insufficiency, pressure ulcers, and burns - as well as for the reduction of scars resulting from surgical ...
More... |
|
Views 22
Comments 0
|
![]() |
| Bookmarks |
| Currently Active Users Viewing This Article: 1 (0 members and 1 guests) | |
| Article Tools | |
| Display Modes | |
|
|
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() |